Gabor E. Linthorst

10.4k total citations · 3 hit papers
89 papers, 7.1k citations indexed

About

Gabor E. Linthorst is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Gabor E. Linthorst has authored 89 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Physiology, 34 papers in Epidemiology and 19 papers in Organic Chemistry. Recurrent topics in Gabor E. Linthorst's work include Lysosomal Storage Disorders Research (61 papers), Trypanosoma species research and implications (33 papers) and Carbohydrate Chemistry and Synthesis (19 papers). Gabor E. Linthorst is often cited by papers focused on Lysosomal Storage Disorders Research (61 papers), Trypanosoma species research and implications (33 papers) and Carbohydrate Chemistry and Synthesis (19 papers). Gabor E. Linthorst collaborates with scholars based in Netherlands, United Kingdom and United States. Gabor E. Linthorst's co-authors include Carla E. M. Hollak, Johannes M. F. G. Aerts, William R. Wilcox, Robert J. Desnick, Dominique P. Germain, Nathalie Guffon, Saskia M. Rombach, Frits A. Wijburg, Ben J. H. M. Poorthuis and Ronald J. A. Wanders and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Gabor E. Linthorst

89 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

2001 1.1k citations William R. Wilcox, Dominique P. Germain et al. profile →
Elevated globotriaosylsphingosine is a hallmark of Fabry disease

2008 566 citations Johannes M. F. G. Aerts, J.E.M. Groener et al. profile →
Rhabdomyolysis: Review of the literature

2014 470 citations Rodi Zutt, Anneke J. van der Kooi et al. Neuromuscular Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabor E. Linthorst Netherlands	41	5.6k	2.8k	1.6k	1.6k	1.6k	89	7.1k
Nathalie Guffon France	35	5.2k 0.9×	2.4k 0.8×	1.1k 0.6×	914 0.6×	1.7k 1.1×	138	6.5k
Stephen Waldek United Kingdom	31	3.9k 0.7×	1.8k 0.6×	1.1k 0.7×	1.0k 0.6×	1.3k 0.8×	57	4.5k
Rossella Parini Italy	38	3.1k 0.6×	1.3k 0.4×	750 0.5×	580 0.4×	1.6k 1.0×	179	5.1k
Kathy Nicholls Australia	37	1.9k 0.3×	1.2k 0.4×	588 0.4×	541 0.3×	1.1k 0.7×	164	4.2k
Deborah Elstein Israel	34	4.3k 0.8×	1.6k 0.6×	1.6k 1.0×	2.1k 1.3×	333 0.2×	201	5.4k
Vassili Valayannopoulos France	39	2.0k 0.4×	834 0.3×	292 0.2×	412 0.3×	900 0.6×	125	4.7k
Hiroyuki Ida Japan	29	2.0k 0.3×	733 0.3×	522 0.3×	729 0.5×	293 0.2×	189	3.5k
Marco Spada Italy	28	1.6k 0.3×	700 0.3×	428 0.3×	415 0.3×	716 0.5×	132	3.1k
Melissa Wasserstein United States	35	1.9k 0.3×	354 0.1×	316 0.2×	297 0.2×	529 0.3×	93	3.3k
Dong‐Kyu Jin South Korea	33	907 0.2×	631 0.2×	129 0.1×	209 0.1×	396 0.3×	261	3.9k

Countries citing papers authored by Gabor E. Linthorst

Since Specialization

Citations

This map shows the geographic impact of Gabor E. Linthorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabor E. Linthorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabor E. Linthorst more than expected).

Fields of papers citing papers by Gabor E. Linthorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabor E. Linthorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabor E. Linthorst. The network helps show where Gabor E. Linthorst may publish in the future.

Co-authorship network of co-authors of Gabor E. Linthorst

This figure shows the co-authorship network connecting the top 25 collaborators of Gabor E. Linthorst. A scholar is included among the top collaborators of Gabor E. Linthorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabor E. Linthorst. Gabor E. Linthorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kemp, Stephan, Irene C. Huffnagel, Gabor E. Linthorst, Ronald J. A. Wanders, & Marc Engelen. (2016). Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history. Nature Reviews Endocrinology. 12(10). 606–615. 170 indexed citations

Fost, Maaike de, Sabrina M. Oussaada, E Endert, et al.. (2015). The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia. Endocrine Connections. 4(2). 86–91. 16 indexed citations

Linthorst, Gabor E., et al.. (2014). [Complaint to the disciplinary board about a resident].. PubMed. 158(3). A6464–A6464. 1 indexed citations

Zutt, Rodi, Anneke J. van der Kooi, Gabor E. Linthorst, Ronald J. A. Wanders, & Marjolein Visser. (2014). Rhabdomyolysis: Review of the literature. Neuromuscular Disorders. 24(8). 651–659. 470 indexed citations breakdown →

Tol, Linda van der, David Cassiman, Gunnar Houge, et al.. (2014). Uncertain Diagnosis of Fabry Disease in Patients with Neuropathic Pain, Angiokeratoma or Cornea Verticillata: Consensus on the Approach to Diagnosis and Follow-Up. JIMD Reports. 17. 83–90. 44 indexed citations

Biegstraaten, Marieke, Gabor E. Linthorst, Ivo N. van Schaik, & Carla E. M. Hollak. (2013). Fabry Disease: A Rare Cause of Neuropathic Pain. Current Pain and Headache Reports. 17(10). 365–365. 11 indexed citations

Bouwman, Machtelt G., Minke H. de Ru, Gabor E. Linthorst, et al.. (2013). Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening. Molecular Genetics and Metabolism. 109(2). 201–207. 23 indexed citations

Wilcox, William R., Gabor E. Linthorst, Dominique P. Germain, et al.. (2011). Anti-α-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry. Molecular Genetics and Metabolism. 105(3). 443–449. 57 indexed citations

Smid, Bouwien E., Saskia M. Rombach, Johannes M. F. G. Aerts, et al.. (2011). Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients. Orphanet Journal of Rare Diseases. 6(1). 69–69. 53 indexed citations

10.

Bouwman, Machtelt G., Heleen Maurice‐Stam, Gabor E. Linthorst, et al.. (2011). Impact of growing up with Fabry disease on achievement of psychosocial milestones and quality of life. Molecular Genetics and Metabolism. 104(3). 308–313. 19 indexed citations

11.

Warnock, David G., Alberto Ortíz, Michael Mauer, et al.. (2011). Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrology Dialysis Transplantation. 27(3). 1042–1049. 123 indexed citations

12.

Rombach, Saskia M., Natashe Lemos Dekker, Machtelt G. Bouwman, et al.. (2010). Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(9). 741–748. 189 indexed citations

13.

Bouwman, Machtelt G., et al.. (2010). 'Doctor Google' ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases. Archives of Disease in Childhood. 95(8). 642–644. 41 indexed citations

14.

Breemen, Mariëlle J. van, Saskia M. Rombach, Nick Dekker, et al.. (2010). Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(1). 70–76. 114 indexed citations

15.

Linthorst, Gabor E., et al.. (2004). Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion. British Journal of Dermatology. 150(3). 575–577. 15 indexed citations

16.

Linthorst, Gabor E., Claudia C. Folman, Johannes M. F. G. Aerts, & Carla E. M. Hollak. (2003). Blood group does not correlate with disease severity in patients with Fabry disease (α-galactosidase A deficiency). Blood Cells Molecules and Diseases. 31(3). 324–326. 4 indexed citations

17.

Blom, Daniël, et al.. (2003). Recombinant Enzyme Therapy for Fabry Disease: Absence of Editing of Human α-Galactosidase A mRNA. The American Journal of Human Genetics. 72(1). 23–31. 50 indexed citations

18.

Cremer, Marion, Harald Schulze, Gabor E. Linthorst, et al.. (1999). Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias. Annals of Hematology. 78(9). 401–407. 28 indexed citations

19.

Borne, A. E. G. Kr. von dem, et al.. (1998). 11 Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine. Baillière s Clinical Haematology. 11(2). 427–445. 1 indexed citations

20.

Linthorst, Gabor E.. (1964). Liver Function after Long-term Progestational Treatment with and Without Oestrogen. BMJ. 2(5414). 920–921. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact